Harish Shantharam

Harish Shantharam

Director of Finance/CFO at ALX ONCOLOGY HOLDINGS INC.

Net worth: 148 200 $ as of 2026-05-30

46 year
Health Technology
Consumer Services

Profile

Harish Shantharam currently works at ALX Oncology Holdings, Inc., as Chief Financial Officer from 2025.
Mr. Shantharam also formerly worked at CymaBay Therapeutics, Inc., as Chief Financial & Accounting Officer in 2024, Gilead Sciences, Inc., as Vice President-Global Commercial Finance from 2011 to 2022, and Amgen, Inc., as Head-Business Development from 2004 to 2011.
Mr. Shantharam received his graduate degree from The University of Texas at Arlington and Masters Business Admin degree from UCLA Anderson School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-30 78,000 ( 0.06% ) 148 200 $ 2026-05-30

Harish Shantharam active positions

CompaniesPositionStart
ALX ONCOLOGY HOLDINGS INC. Director of Finance/CFO 2025-01-20

Former positions of Harish Shantharam

CompaniesPositionEnd
CYMABAY THERAPEUTICS, INC. Director of Finance/CFO 2024-03-21
GILEAD SCIENCES, INC. Corporate Officer/Principal 2022-04-30
AMGEN INC. Corporate Officer/Principal 2011-10-31
See the detail of Harish Shantharam's experience

Training of Harish Shantharam

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

64

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Harish Shantharam